Kicki Johansson
Directeur des opérations chez WNTRESEARCH AB
Provenance du réseau au premier degré de Kicki Johansson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 19 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kicki Johansson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Wntresearch Incentive AB | Director/Board Member Director/Board Member Director/Board Member | ||
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| PROBI AB | Biotechnology | Director/Board Member Director/Board Member | |
| IDOGEN AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| University of Gothenburg | College/University | Corporate Officer/Principal Masters Business Admin | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Uppsala | College/University | Graduate Degree Graduate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
| LIDDS AB | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| Ub-Consulting AB | Chief Executive Officer | ||
| EVAXION BIOTECH A/S | Biotechnology | Chief Executive Officer | |
| LIPUM AB | Biotechnology | Chairman | |
| REDWOOD PHARMA AB | Pharmaceuticals: Major | Chairman | |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| OxyPharma AB | Chief Executive Officer | ||
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chief Executive Officer | |
| XINTELA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Chief Operating Officer | |
| ALZINOVA AB | Pharmaceuticals: Major | Director/Board Member | |
Innovativa Mindre Life Science
 Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Miscellaneous Commercial Services | Director/Board Member | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member | |
| NIMUTAN AB (PUBL) | Household/Personal Care | Director/Board Member | |
ScientificMed Tech AB
 ScientificMed Tech AB Miscellaneous Commercial ServicesCommercial Services ScientificMed Tech AB provides cancer therapies development, clinical research and health care services. The company was founded by Jan Fjellström and Johan Cederlund and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| Copenhagen Business School | College/University | Graduate Degree | |
| Asklepios Medicin Handelsbolag | Corporate Officer/Principal | ||
| The European Medicines Agency | National Agency | Corporate Officer/Principal | |
| University of Oxford | College/University | Corporate Officer/Principal | |
| The University of Manchester | College/University | Corporate Officer/Principal | |
| Handelshögskolan i Göteborg | College/University | Undergraduate Degree | |
| Nordic Alliance Tankers AB | Director/Board Member | ||
| Infans Capital AB | Director/Board Member | ||
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
 Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sand Medical AB
 Sand Medical AB Medical/Nursing ServicesHealth Services Sand Medical AB provides medical care services. The private company is based in Stockholm, Sweden. | Medical/Nursing Services | Chairman | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | General Counsel | |
| Intellectual Property Enabler Stockholm AB | Director/Board Member | ||
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
| Caliso Utveckling AB | Chairman | ||
Ondosis AB
 Ondosis AB Pharmaceuticals: MajorHealth Technology Ondosis AB delivers flexible and individualized dosing of oral medicines formulated as micro units. The company was founded by Martin Olovsson in 2017 and is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| Apotekarsocieteten | Corporate Officer/Principal |
Statistiques
Internationale
| Suède | 40 |
| Etats-Unis | 5 |
| Danemark | 4 |
| Royaume-Uni | 4 |
| Chine | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 10 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
| Government | 2 |
Opérationnelle
| Director/Board Member | 56 |
| Corporate Officer/Principal | 34 |
| Chief Executive Officer | 18 |
| Chairman | 18 |
| Chief Tech/Sci/R&D Officer | 10 |
Relations les plus connectées
| Insiders | |
|---|---|
| Dennis Bang Henriksen | 19 |
| Peter Jan Sture Ström | 15 |
| Ulf Björklund | 14 |
| Jan Nilsson | 12 |
| Per-Ola Forsberg | 11 |
| Christer Nordstedt | 10 |
| Anders Rabbe | 9 |
| Per Norlén | 9 |
| Pernilla Sandwall | 8 |
| Tommy Evert Andersson | 6 |
| Peter Morsing | 6 |
| Martin Olovsson | 6 |
| Jonas Bergh | 6 |
| Gudrun Anstrén | 5 |
| Anders Tidfors | 5 |
- Bourse
- Insiders
- Kicki Johansson
- Connexions Sociétés
